Upload
hamed-hamed
View
217
Download
4
Embed Size (px)
Citation preview
PIGESTIVE MULTIENZYME PREFORBULATIGN STABILITY SCREENING USING DIFFERENTIAL
SCANNING CALORIIllETRY
Hamed Hamed El-Shattawy
Department of Pharmaceutics, Faculty of Pharmacy Al-Azhar University, Nasr-City, Cairo, Egypt.
ABSTRACT
Pifferential scanning calorimetry was used for assessing the compatibility in the solid state of pepsin- diastase, pepsin-pancreatin, pancreatin-diastase and pepsin-diastase-pancreatin mixtures using uncoated and Eudragit coated enzymes. The enthalpy change (cal/g) of the resulting thermogram transitions indicated pepsin- diastase and pancreatin-diastase mixtures to be compati- ble, and pepsin-pancreatin and pepsin-diastase-pancreatin mixtures to be incompatible when uncoated enzymes were used while compatible when coated enzymes with Eudragit were used.
I NTRODUCT I ON El-Shattawy et al. previously used differential
scanning calorimetry (DSC) as a screening technique for assessing the compatibility of aspartame' ' 2, anhydrous ampicillin3, cephalexin4 and erythromycin5 with some of the direct compression excipients. The compatibilities of anhydrous ampicillin, ampicillin trihydrate and cephalexin with anhydrous dextrose and with aspartame were also investigated by the same authors . In 6-8
1435
Copyright 6 1983 by Marcel Dekker, Inc.
Dru
g D
ev I
nd P
harm
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f B
ritis
h C
olum
bia
on 1
2/10
/14
For
pers
onal
use
onl
y.
1436 EL-SHATTAWY
this investigation, the author used r S C in preformulation stability studies involving pepsin, diastase and pancreatin.
studied extensively with regard to protein structures and biochemical functions9-'' . Pepsin solutions are reduced in proteolytic activity by agitation and storage,particul- arly at or above normal room temperatures12. The proteo- lytic activity of pepsin is also destroyed by pancreatic
enzymes in neutral solution . Enzyme stability in the solid state is complicated
and is readily affected by factors such as temperature,
described the application of the Weibull distribution function to solid-state enzyme inactivation in a study involving microbial lipases, microbial a-amylase, pancreatin and diastase.
Graf and Sakr" studied the effect of direct compre- ssion excipients on the characteristics of Stomach Extract tablets produced under standardized manufacturing condit- ions. problems involved in the manufacture of satisfactory pan- creatic enzymes oral solid dosage forms due to the very complex nature of the enzymes and their great liability to quickly loose activity during manufacture, on storage and in the gastro-intestinal tract before reaching their specific site of action.
effects of formulation factors on the stability and bio-
availability of pancreatic enzymes tablets manufactured
by the direct compression technique,
mixed digestive enzymes, no information is available in the pharmaceutical literature about the problem of enzyme-
enzyme interaction, in the solid state. In this study the author investigated the compatibility in the solid state of pepsin-diastase, pepsin-pancreatin, pancreatin- diastase and pepsin-diastase-pancreatin mixtures using
Enzyme inactivation in aqueous systems has been
12
humidity, and co-existing substances13 . Sugiura et al. 13
The same authors" reported that there are many
Graf et al. 15-17 studied the
Although many commercial preparations containing
Dru
g D
ev I
nd P
harm
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f B
ritis
h C
olum
bia
on 1
2/10
/14
For
pers
onal
use
onl
y.
DIFFERENTIAL SCANNING CALORIMETRY 1437
uncoated and coated enzymes. This is achieved by compar- ing the PSC thermograms of the individual enzymes in the mixture and finally on the mixture itself. Although it cannot be’conclusively stated that an interaction incom- patibility will occur during storage at room temperature , PSC can distinguish between enzyme mixtures unlikely to cause a problem and those that may cause trouble and thereby a more rational approach to early formulation designs can be established.
18
EXPERILEIiTAL Mate r i a1 s
The following materials were used: pepsin,diastase (supplied by Arab Drug Company), pancreatin (supplied by Memphis Chemical Company), Eudragit E and Eudragit S (Rohm and Haas Co.,Inc.). All other chemicals were USP or analytical grade.
Jvlanufacture of Enzyme Granules
pepsin, 95% ethanol for diastase and 90% isopropanol for pancreatin. The mass was forced through an 800 p sieve and the granules were dried in a vacuum desiccator. The obtained irregular granules were rounded by placing in an ERWEKA coating pan (type LJG) f o r 15 minutes at constant speed. The granules were then passed through an 800 p
sieve and retained over a 630 p sieve using an ERWEKA screen analyzer (type VT). These retained granules were
collected f o r direct coating.
Coating of the Granules Eudragit E in chloroform, Eudragit E in 2:3 acetone-
isopropanol mixture and Eudragit S in 1:l acetone-isopro- panol mixture were used for the coating of pepsin,diastase and pancreatin, respectively.
The rounded granules(200g) were sprayed in an ERWEKA coating pan with a solution of 10 g Eudragit in 500 ml of the respective organic solvent, by means of an air-pressure
The enzyme powder was massed with chloroform for
Dru
g D
ev I
nd P
harm
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f B
ritis
h C
olum
bia
on 1
2/10
/14
For
pers
onal
use
onl
y.
1438 EL-SHATTAWY
spray gun. app l i ed i n 10 m l p o r t i o n s over a pe r iod of 2-3 hours .
spray ing was stopped a t occas iona l i n t e r v a l s , and t h e con ten t s of t h e pan were d r i e d wi th co ld a i r . coated g ranu le s were d r i e d overn ight i n a vacuum d e s i c c a t o r .
P i f f e r e n t i a l Scanninf?: Calor imetry Samples (3 -9 mg) were weighed and encapsula tea i n
f la t -bot tomed aluminum pans wi th crimped-on l i d s . The samples were hea ted i n a n atmosphere o f n i t r o g e n and t h e r - mograms were obta ined on a Perkin-Elmer TSC-1B D i f f e r e n t i a l Scanning Calor imeter . Thermograms were obta ined by h e a t i n g
a t a cons t an t h e a t i n g r a t e of 10°C p e r minute, a cons t an t range s e t t i n g o f 8 mcal p e r second and recorded a t a cons t an t c h a r t speed of one inch p e r minute. The ind iv id - u a l enzymes and t h e mixtures the reo f were heated over t h e temperature range 30 t o 3 O O O C .
The t o t a l amount of t h e polymer s o l u t i o n was The
F i n a l l y t h e
The a r e a under t h e d i f f e r e n t i a l scanning c a l o r i m e t r i c
hea t ing curve was measured us ing a K 6; E p lan ime te r and t h e hea t of t r a n s i t i o n w a s t hen c a l c u l a t e d as desc r ibed
1 prev ious ly . A t least two r e p l i c a t e s made f o r each DSC thermogram.
RESULTS AND LISCUSSION
The DSC thermogram o f peps in (Trace 1 of F igure 1) showed two endothermic peaks, t h e first one wi th a t r a n - s i t i o n temperature range from 134-147OC and wi th a maximum peak of t r a n s i t i o n a t 14OoC, t h e second one w i t h a t r a n - s i t i o n temperature range from 188-222OC and wi th a maximum peak o f t r a n s i t i o n a t 208OC. The DSC thermogram of coated peps in (Trace 2 of F igure 1) showed t h e same two enuo- thermic peaks wi th a s l i g h t s h i f t t o h ighe r tempera tures as regard t h e t r a n s i t i o n temperature range (134-1500 and 190-228OC) and t h e maximum peak of t r a n s i t i o n (143°C and 21OOC) of t h e two t r a n s i t i o n s , r e s p e c t i v e l y .
Uncoated and coated d i a s t a s e e x h i b i t no t r a n s i t i o n when scanned over t h e temperature range of 30 t o 300°'C.
Dru
g D
ev I
nd P
harm
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f B
ritis
h C
olum
bia
on 1
2/10
/14
For
pers
onal
use
onl
y.
DIFFERENTIAL SCANNING CALORIMETRY 1439
100 170 240
Temperature (OC)
Figure 1: Thermo rams o f the i nves t i ga ted enzymes and mixtures thereof . Key: 9 1) uncoated pepsin, 3 mg; ( 2 ) coated pepsln, 3 mg; (3) uncoated 1:l pepsin-diastase mixture, 6 mg; (4 ) coated 1:l pepsin-diastase mixture, 6 mg; ( 5 ) uncoated pancreat in, 3 mg; (6 ) coated pancreat in, 3 mg; ( 7 ) uncoated 1:l pepsin-pancreat in mixture, 3 mg; (8) coated 1:l pepsin-pancreat in mixture, 3 mg; (9) uncoated 1:l pancreat in-diastase mixture, 6 mg; (10) coated 1:l pancreat in-diastase mixture, 6 mg; (11) uncoated 1:l: l pepsin- diastase-pancreat in mixture, 9 mg; (12) coated 1: l : l pepsin-diastase- pancreat in mixture, 9 mg.
Therefore , rSC thermograms o f peps in -d ia s t a se mixtures w i l l r e f l e c t t h e c h a r a c t e r i s t i c f e a t u r e s of t h e thermo- grams o f peps in i f no i n t e r a c t i o n occurred. T h i s i s indeed t h e case as seen i n Traces 3 and 4 o f F igure 1. Some change i n peak shape and height- to-width r a t i o w a s expected because of p o s s i b l e d i f f e r e n c e s i n t h e mixture
Dru
g D
ev I
nd P
harm
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f B
ritis
h C
olum
bia
on 1
2/10
/14
For
pers
onal
use
onl
y.
1440 EL- SHATTAWY
sample geometry19. peps in -d ia s t a se , uncoated and coated enzyme mixtures was found t o be c l o s e t o t h e p red ic t ed va lues c a l c u l a t e d from t h e exac t percentage c o n t r i b u t i o n of peps in t o t h e t o t a l en tha lpy change of t h e mixtures (Table 1) i n d i c a t - ing no i n t e r a c t i o n between peps in and d i a s t a s e i n the s o l i d s t a t e under t h e experimental c o n d i t i o n s .
The en tha lpy change ( c a l / g ) of
The rSC thermogram of p a n c r e a t i n (Trace 5 of F igure 1 ) showed two endothermic peaks, t h e f i rs t one wi th a t r a n - s i t i o n temperature range from 12E-145"C and w i t h a maximum peak of t r a n s i t i o n a t 1380C, t h e second one wi th a t r a n - s i t i o n temperature range from 191-213OC and wi th a maximum peak of t r a n s i t i o n a t 2 O 7 O C . The CSC thermogram of coated p a n c r e a t i n (Trace 6 of F igure 1 ) showed t h e same two endothermic peaks wi th a s l i g h t s h i f t t o h ighe r tempera- t u r e s as regard t h e t r a n s i t i o n temperature range (126-147O and 191-219OC) and t h e maximum peak of t r a n s i t i o n (140°C and 208OC) of t h e two t r a n s i t i o n s , r e s p e c t i v e l y .
The DSC thermogram of peps in-pancrea t in uncoated enzyme mixture (Trace 7 o f F igure 1 ) showed t h r e e enclo- thermic peaks. The first one wi th a t r a n s i t i o n temperature range from 129-149OC and wi th a maximum peak of t r a n s i t i o n a t 14OOC corresponding t o t h e f i r s t peaks o f peps in and panc rea t in . The second peak with a t r a n s i t i o n tempera- t u r e range from l50-166OC and wi th a maximum peak of t r a n - s i t i o n a t 160OC is a new t r a n s i t i o n . The t h i r d peak wi th a t r a n s i t i o n temperature range from 180-213OC and wi th a maximum peak of t r a n s i t i o n a t 2OOOC corresponding t o t h e second peaks of peps in and panc rea t in . The en tha lpy change (cal/g) of t h e f irst peak was found t o be 62.23% t h e p red ic t ed v a l u e , c a l c u l a t e d from t h e exac t percentage c o n t r i b u t i o n of peps in and p a n c r e a t i n t o t h e t o t a l en tha lpy change of t h e mixture , while t h e en tha lpy change of t h e t r a n s i t i o n corresponding t o t h e second peaks of peps in and p a n c r e a t i n was found t o be 49.E7% t h e p red ic t ed va lue (Table 1) i n d i c a t i n g i n t e r a c t i o n between peps in and pan- c r e a t i n i n t h e s o l i d s t a t e under t h e exper imenta l condi-
Dru
g D
ev I
nd P
harm
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f B
ritis
h C
olum
bia
on 1
2/10
/14
For
pers
onal
use
onl
y.
i3
.F
8 F 1 4.90
5.25
93.33
10.49
10.11
103.76 1:
ii
Ent
halp
y C
hang
e ,
Cal
/g
Fir
st
Tra
nsi
tio
n
Seco
nd T
ran
siti
on
**
DS
C Th
erm
ogra
m o
f:
*+
Act
ual
Pre
dict
ed
% A
ctua
l P r
ed i c t
ed
k
peps
in-D
iast
ase
(1: 1
unc
oate
d m
ixtu
re)
peps
in-D
iast
ase
(1:l c
oate
d m
ixtu
re)
Pep
si n-
Pan
crea
ti n
(1:l u
ncoa
ted
mix
ture
Pep
sin-
Pan
crea
ti n
( 1
: 1 c
oate
d m
ixtu
re)
Pan
crea
ti n-
Di a
stas
e (1: 1 u
ncoa
ted
mix
ture
)
lpan
crea
ti n-
Di a
stas
e (1:l c
oate
d m
ixtu
re)
Pep
si n
-Dia
stas
e-P
ancr
eatin
(1
: 1: 1
unc
oate
d m
ixtu
re)
Pep
sin-
Di a
stas
e-P
ancr
eati
n
5.70
5.25
108.57
10.46
10.11
103.46
0
.. B
8.09
13.00
62.23
10.18
20.41
49.87
I4 13.01
13.00
100.08
20.09
20.41
98.43
3
7.41
7.75
95.61
9.46
10.30
91.84
I 7.73
7.75
99.74
10.26
10.30
99.61
63.19
1 I
8.76
I 8.66
I 101.15
1 13.61
13.61
1 lO
O.OO
[
7.42
8.66
85.68
8.60
13.61
* Th
e en
thal
py c
hang
es
(cal
/g)
for
the
coat
ed a
nd u
ncoa
ted
enzy
mes
wer
e fo
und
to b
e th
e sa
me
whe
n ca
lcu
lati
on
s w
ere
norm
aliz
ed t
o c
ompa
re t
he d
ata
on a
n eq
ufva
lent
wei
ght
basi
s an
d w
ere
foun
d to
be 10.50
and 20.22
cal/
g f
or
peps
in's
fi
rst
and
seco
nd t
rans
itio
ns,
resp
ecti
vely
, 15.49
and 20.60
cal/
g f
or
panc
reat
in's
fir
st a
nd s
econ
d tr
an
siti
on
s,
resp
ecti
vely
, an
d no
ent
halp
y ch
ange
fo
r di
asta
se a
s it
exh
ibit
s no
tra
nsi
tio
n.
Pre
dict
ed v
alue
s ar
e ca
lcul
ated
fro
m t
he e
xact
per
cent
age
con
trib
uti
on
of
each
ing
redi
ents
to
the
to
tal
enth
alpy
ch
ange
of
the
mix
ture
.
** I( 1 : 1
: 1 c
oate
d m
ixtu
re)
I I
i
Dru
g D
ev I
nd P
harm
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f B
ritis
h C
olum
bia
on 1
2/10
/14
For
pers
onal
use
onl
y.
1442 EL- S HATTAWY
12 t i o n s . Th i s f i n d i n g i s i n agreement wi th l i t e r a t u r e t h a t t h e p r o t e o l y t i c a c t i v i t y of peps in i s des t royed by p a n c r e a t i c enzymes i n n e u t r a l s o l u t i o n .
mixture (Trace 8 of Figure 1 ) showed a l s o t h r e e endothermic peaks as i n t h e case of t h e uncoated enzyme mix tu re ,bu t t h e t r a n s i t i o n temperature range and t h e maximum peak of t r a n s i t i o n s h i f t e d t o h ighe r temperature and t h e two main peaks corresponding t o peps in and p a n c r e a t i n a r e more d i s t i n c t . The en tha lpy change ( c a l / g ) o f t h e s e two peaks was found t o be c l o s e t o t h e p red ic t ed va lues (Table 1 ) i n d i c a t i n g no i n t e r a c t i o n between peps in coated wi th Eudragi t E , and p a n c r e a t i n coated wi th Eudragi t S i n t h e s o l i d s t a t e under t h e experimental cond i t ions .
p a n c r e a t i n - d i a s t a s e , uncoated and coated enzyme mix tu res , r e s p e c t i v e l y . The en tha lpy change ( c a l / g ) of panc rea t in - d i a s t a s e , uncoated and coated enzyme mixtures w a s found t o be c l o s e t o t h e p red ic t ed va lues c a l c u l a t e d from t h e exac t percentage c o n t r i b u t i o n o f p a n c r e a t i n t o t h e t o t a l en tha lpy change of t h e mixture (Table 1) i n d i c a t i n g no i n t e r a c t i o n between p a n c r e a t i n and d i a s t a s e i n t h e s o l i d s t a t e under t h e experimental cond i t ions .
Traces 11 and 12 of F igure 1 are t h e thermograms of pepsin-diastase-pancreatin, uncoated and coated enzyme mixtures , r e s p e c t i v e l y . The en tha lpy change ( c a l / g ) of t h e two main peaks of t h e uncoated enzyme mixture was found t o be 85.68 and 63.19%, r e s p e c t i v e l y , t h e p r e d i c t e d va lues while t hose of t h e coated enzyme mixture was found t o be 101.15 and loo%, r e s p e c t i v e l y (Table 1 ) r e f l e c t i n g t h e s t a b i l i t y o f t h e i n v e s t i g a t e d coated enzymes mixture .
The PSC thermogram of peps in-pancrea t in coated enzyme
Traces 9 and 1 0 of F igure 1 a r e t h e thermograms o f
ACKNOWLEDGEMENTS
The au tho r acknowledges t h e Arab Crug Company and Memphis Chemical Company, Ca i ro , Egypt. Thanks t o t h e IPPH Department, School o f Pharmacy, Purdue Un ive r s i ty , West La faye t t e , I N 47907, U.S.A. Thanks and g r a t e f u l
Dru
g D
ev I
nd P
harm
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f B
ritis
h C
olum
bia
on 1
2/10
/14
For
pers
onal
use
onl
y.
DIFFERENTIAL SCANNING CALORIMETRY 1443
appreciation are extended to Cr. Dane 0. Kildsig, Dr. Garnet E. Peck and Judi A. Yost f o r continuous help.
REFERENCES
1. H.H. El-Shattawy, G.E. Peck and D.O. Kildsig, Drug
2 . H.H. El-Shattawy, D . O . Kildsig and G.E. Peck, ibid,
3. H.H. El-Shattawy, ibid, in press. 4. H.H. El-Shattawy, D . O . Kildsig and G.E. Peck, ibid,
5. H.H. El-Shattawv, C . O . Kildsig and G.E. Peck, ibid,
6. H.H. El-Shattawy, D.0. Kildsig and G.E. Peck, ibid,
7. H.H. El-Shattawy, D . O . Kildsig and G.E. Peck, ibid,
8. H.H. El-Shattawy, D.O. Kildsig and G.E. Peck, ibid,
9. S. Nakayama and Y. Kano, J. Biochem. (Tokyo) &, 25
Dev. and Industrial Pharm., u, 605 (1981) .
in press.
in press.
in press.
in press.
in press.
in press.
(1957). 10. C. Tanford, J. Am. Chem. SOC., 86, 2.050 (1964) . 11. C . Tanford, K.C. Anue and A. Ikai, J. Mol. Biol.,
12. A . Wade and J.E.F. Reynolds, eds., "Extra Pharmaco- 2.2, 185 (1973) .
peia-Martindale ", 27th ed., The Pharmaceutical Press, London, 1977, p. 582.
J. Pharm. Sci., 68, 1381 (1979) . 13 . M. Sugiura, M. Kurobe, S. Tamura and S. Ikeda,
14. E. Graf and A. Sakr, Pharm. Ind., 4.0, 165 (1978) , 15. E. Graf and A. Sakr, ibid, 4 l , 66 (1979) . 16. E. Graf, A. Sakr and A. Nada, ibid, 42, 1031 (1980). 17 . E. Graf, A. Sakr and A. Nada, ibid, Q, 282 (1981) . 18. K.C. Lee and J.A. Hersey, J. Pharm. Pharmac., 29,
515 (1977). 19. E.S. Watson, M.J. O'Neill, J. Justin and N. Brenner,
Anal. Chem., s, 1233 (1964) .
Dru
g D
ev I
nd P
harm
Dow
nloa
ded
from
info
rmah
ealth
care
.com
by
Uni
vers
ity o
f B
ritis
h C
olum
bia
on 1
2/10
/14
For
pers
onal
use
onl
y.